R&D
Advanced biopharmaceutical development company
Mitochondria
Mitochondria are one of the organelles within cells and are known to synthesize the energy required by the cell.
Recently, mitochondria have also been recognized as a key to life and death, such as aging and disease,
and play an important role in maintaining a healthy life.
Mitochondria, which contain their own DNA, are intracellular organelles that lack a damage-repair mechanism.
As a result, damage caused by reactive oxygen species (ROS) accumulates, leading to various diseases and aging.
Our company has secured core technologies related to the control of mitochondria within cells (such as isolation, processing, and storage) and is accelerating the development of advanced biopharmaceuticals and regenerative medicine based on these technologies.
Our company has secured core technologies related to the control of mitochondria within cells (such as isolation, processing, and storage) and is accelerating the development of advanced biopharmaceuticals and regenerative medicine based on these technologies.
Advanced Biopharmaceuticals
MITO ADD™
MITO ADD, a mitochondrial treatment under development, is an advanced biopharmaceutical to treat tendinopathy, one of the intractable diseases. (Selected as national project in 2022)
It is a new drug that treats incurable diseases by injecting healthy mitochondria into the affected area and using mitochondria inflammatory response control and cell and tissue regeneration.
